Silicon Valley Startup Raises $200 Million for Genetically Engineered Military Dogs

A new Silicon Valley venture, Warhound, has secured $200 million in funding to genetically engineer military dogs. The startup, which has reportedly achieved a $1.2 billion valuation without yet producing any modified animals, was co-founded by Palmer Luckey, founder of defense technology firm Anduril, and Ben Lamm, known for his work with Colossal Biosciences.

Warhound intends to clone elite military and police dogs, primarily Belgian Malinois, Labrador Retrievers, and German Shepherds, with the goal of eliminating common health issues like hip dysplasia. The company has already collected blood samples from high-performing working dogs used by armed forces, law enforcement, and first responders. Lamm indicated that future genetic modifications could include incorporating olfactory receptor genes from wolves to enhance scent detection capabilities.

Beyond genetic enhancements, Warhound plans to integrate technology from Luckey's Anduril into its canine creations. This includes advanced body armor, sensors, software, and systems aimed at improving battlefield awareness. Lamm clarified that this technology would involve external equipment rather than surgically implanted electronics, drawing a parallel to concepts like Captain America's enhanced abilities and Iron Man's technological suit.

The startup aims to reduce the U.S. military's reliance on European breeders for working dogs and establish a domestic source of genetically improved animals for the Pentagon, police departments, and emergency services. Investors include venture capital firm Sequoia Capital, ARK Invest, and In-Q-Tel, which focuses on national security technology.

David Spirk, former Pentagon chief data officer, is leading Warhound's daily operations, with Lamm serving on the board. Colossal Biosciences holds a stake in Warhound, while Luckey and Anduril do not have equity.

The project faces scientific challenges, as reliably producing animals with enhanced abilities without introducing new health problems remains unproven. Concerns have also been raised regarding the welfare of genetically engineered animals and the reproductive difficulties associated with cloning. Warhound stated it plans to operate under the guidance of the American Humane Society.

The company anticipates its first genetically engineered puppies to be born in early 2027.